BRATISLAVA – Z trhu sa s\u0165ahuj\u00fa dve \u0161ar\u017ee lieku ur\u010den\u00e9ho na lie\u010dbu akn\u00e9. D\u00f4vodom je, \u017ee zistili nedostatok v\u00a0kvalite lieku. \u0160t\u00e1tny \u00fastav pre kontrolu lie\u010div ubezpe\u010duje, \u017ee lie\u010dba pacientov nebude ohrozen\u00e1, preto\u017ee s\u00fa dostupn\u00e9 in\u00e9 lieky s rovnak\u00fdmi terapeutick\u00fdmi indik\u00e1ciami.<\/p>\n
\u0160t\u00e1tny \u00fastav pre kontrolu lie\u010div (\u0160\u00daKL) informuje o stiahnut\u00ed lieku „Aknemycin Plus“, \u0160\u00daKL k\u00f3d: 33163 z trhu. \u00dastav pribli\u017euje, \u017ee s\u0165ahovanie z trhu sa vz\u0165ahuje na\u00a0\u0161ar\u017eu s \u010d\u00edslom\u00a051316X2\u00a0s d\u00e1tumom exspir\u00e1cie marec 2027 a\u00a0\u0161ar\u017eu s\u00a0\u010d\u00edslom 541193\u00a0s\u00a0d\u00e1tumom exspir\u00e1cie okt\u00f3ber 2027.\u00a0Liek sa s\u0165ahuje z \u00farovne distribu\u010dn\u00fdch spolo\u010dnost\u00ed, lek\u00e1rn\u00ed a zdravotn\u00edckych zariaden\u00ed.<\/p>\n
„D\u00f4vodom stiahnutia predmetn\u00fdch \u0161ar\u017e\u00ed lieku\u00a0Aknemycin Plus, sol der 1\u00d725 ml\u00a0je\u00a0zisten\u00fd nedostatok v\u00a0kvalite lieku \u2013 nes\u00falad v parametri vzh\u013ead vn\u00fatorn\u00e9ho obalu lieku,“ vysvet\u013euje \u0160\u00daKL na svojom webe.<\/p>\n
Na \u010do sa liek pou\u017e\u00edva<\/p>\n
Aknemycin Plus derm\u00e1lny roztok\u00a0je liek na lok\u00e1lnu lie\u010dbu akn\u00e9, pribli\u017euje \u00fastav. Obsahuje kombin\u00e1ciu antibiotika erytromyc\u00ednu a retinoidu tretino\u00ednu, ktor\u00e9 p\u00f4sobia priamo na pr\u00ed\u010diny vzniku akn\u00e9. Je ur\u010den\u00fd najm\u00e4 pre pacientov s mastnou (seboroickou) poko\u017ekou a pou\u017e\u00edva sa na lie\u010dbu nez\u00e1palov\u00fdch foriem akn\u00e9 (komed\u00f3ny), ako aj z\u00e1palov\u00fdch prejavov (papuly a pustuly). Erytromyc\u00edn obmedzuje rast bakt\u00e9ri\u00ed a p\u00f4sob\u00ed protiz\u00e1palovo, zatia\u013e \u010do tretino\u00edn podporuje obnovu poko\u017eky, uvo\u013e\u0148uje upchat\u00e9 p\u00f3ry a normalizuje rohovatenie ko\u017ee.<\/p>\n
„Lie\u010dba pacientov nebude ohrozen\u00e1, preto\u017ee na slovenskom trhu s\u00fa dostupn\u00e9 in\u00e9 lieky s rovnak\u00fdmi terapeutick\u00fdmi indik\u00e1ciami. Rozhodnutie o\u00a0vhodnej lie\u010dbe mus\u00ed stanovi\u0165 o\u0161etruj\u00faci lek\u00e1r,“ kon\u0161tatuje na z\u00e1ver \u0160\u00daKL.<\/p>\n","protected":false},"excerpt":{"rendered":"BRATISLAVA – Z trhu sa s\u0165ahuj\u00fa dve \u0161ar\u017ee lieku ur\u010den\u00e9ho na lie\u010dbu akn\u00e9. D\u00f4vodom je, \u017ee zistili nedostatok…\n","protected":false},"author":2,"featured_media":45838,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32],"tags":[18009,19086,34,37,33,43,40,39,42,41,36,19085,19084,38,35],"class_list":{"0":"post-45837","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-spravy","8":"tag-akne","9":"tag-aknemycin-plus","10":"tag-headlines","11":"tag-hlavne-spravy","12":"tag-news","13":"tag-sk","14":"tag-slovak","15":"tag-slovakia","16":"tag-slovencina","17":"tag-slovensko","18":"tag-spravy","19":"tag-statny-ustav-pre-kontrolu-lieciv-sukl","20":"tag-stiahnutie-lieku","21":"tag-titulky","22":"tag-top-stories"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@sk\/116414636542055765","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts\/45837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/comments?post=45837"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts\/45837\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/media\/45838"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/media?parent=45837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/categories?post=45837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/tags?post=45837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}